GRAIL, Inc. (GRAL) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Grail, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:05.113 Good day, ladies and gentlemen, and welcome to the Grail second quarter 2026 earnings 00:00:05.113 -- 00:00:09.456 call. At this time, all participants are in listen-only mode. 00:00:09.456 -- 00:00:13.497 After the speaker's presentation, there will be a question and answer session. 00:00:13.497 -- 00:00:16.639 Please be advised that this conference call is being recorded. 00:00:16.639 -- 00:00:20.340 Grail Investor Relations, please begin. 00:00:20.669 -- 00:00:23.691 Thank you, and thank you all for joining us today. 00:00:23.691 -- 00:00:28.734 On the call are Josh Ofman, our Chief Executive Officer, Aaron Freidin, 00:00:28.734 -- 00:00:33.896 Chief Financial Officer, Sir Harpal Kumar, Chief Scientific Officer and 00:00:33.896 -- 00:00:39.039 President, Global Clinical and Medical Affairs, and Andy Partridge, Chief 00:00:39.039 -- 00:00:40.993 Growth Officer. 00:00:40.993 -- 00:00:46.658 I'll remind you that we'll be making forward-looking statements based on current expectations. 00:00:46.658 -- 00:00:51.802 It's our intent that all statements other than statements of historical fact, 00:00:51.802 -- 00:00:57.406 including statements regarding our anticipated financial results and commercial activity, 00:00:57.406 -- 00:01:02.631 will be covered by the safe harbor provisions for forward-looking statements under 00:01:02.631 -- 00:01:05.731 federal securities laws. 00:01:05.813 -- 00:01:10.197 Forward-looking statements are subject to risks and uncertainties. 00:01:10.197 -- 00:01:16.321 Actual events or results may differ materially from those projected or discussed. 00:01:16.321 -- 00:01:21.526 All forward-looking statements are based upon currently available information and GRAIL 00:01:21.526 -- 00:01:25.425 assumes no oblig...